Record mula sa primary source
katayuan: ACTIVE_NOT_RECRUITING → RECRUITING; mga bansa: {'total_sites': 252, 'us_sites': 30} → {'total_sites': 253, 'us_sites': 30}
Cullinan (CGEM) ay magpresenta ng zipalertinib REZILIENT2 CNS data sa ESMO 2026
Cullinan: zipalertinib REZILIENT3 Phase 3 data sa IASLC 2026 WCLC Presidential Symposium